# Bristol-Myers Squibb Company (BMY) — Q2-2008 Earnings Results

**Report date:** 2008-07-24 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2008

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Reports Q2 2008 Earnings, Stock Up 1.05%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.43 | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management emphasized their commitment to innovation and maintaining a strong pipeline. They did not provide any updates on future guidance.

**Key quotes:**

> Management did not provide specific guidance for the upcoming quarters.

> The company remains focused on its core therapeutic areas.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Bristol Myers Squibb's earnings report showed an EPS of $0.43, although no revenue figures were disclosed. The stock reacted positively, rising by 1.05%, likely due to the earnings figure and management's focus on their pipeline. However, the lack of guidance may leave investors cautious about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2008_